612 related articles for article (PubMed ID: 27893843)
21. Awareness of nicotine replacement therapy among South African smokers and their interest in using it for smoking cessation when provided for free.
Agaku IT; Ayo-Yusuf OA
Nicotine Tob Res; 2014 Apr; 16(4):500-5. PubMed ID: 24336347
[TBL] [Abstract][Full Text] [Related]
22. Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy.
Biazzo LL; Froshaug DB; Harwell TS; Beck HN; Haugland C; Campbell SL; Helgerson SD
Nicotine Tob Res; 2010 Jun; 12(6):567-73. PubMed ID: 20378640
[TBL] [Abstract][Full Text] [Related]
23. [Smoking cessation among HIV smokers: Experience of a French hospital-based smoking cessation service].
Choulika S; Le Faou AL
Encephale; 2017 Apr; 43(2):110-113. PubMed ID: 27339798
[TBL] [Abstract][Full Text] [Related]
24. Over-the-counter availability of nicotine replacement therapy and smoking cessation.
Hyland A; Rezaishiraz H; Giovino G; Bauer JE; Michael Cummings K
Nicotine Tob Res; 2005 Aug; 7(4):547-55. PubMed ID: 16085526
[TBL] [Abstract][Full Text] [Related]
25. Prescribing Prevalence, Effectiveness, and Mental Health Safety of Smoking Cessation Medicines in Patients With Mental Disorders.
Taylor GMJ; Itani T; Thomas KH; Rai D; Jones T; Windmeijer F; Martin RM; Munafò MR; Davies NM; Taylor AE
Nicotine Tob Res; 2020 Jan; 22(1):48-57. PubMed ID: 31289809
[TBL] [Abstract][Full Text] [Related]
26. Quitting smoking before and after varenicline: a population study based on two representative samples of US smokers.
Zhu SH; Cummins SE; Gamst AC; Wong S; Ikeda T
Tob Control; 2016 Jul; 25(4):464-9. PubMed ID: 26283713
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands.
Hoogendoorn M; Welsing P; Rutten-van Mölken MP
Curr Med Res Opin; 2008 Jan; 24(1):51-61. PubMed ID: 18021492
[TBL] [Abstract][Full Text] [Related]
28. Factors Correlated with Smoking Cessation Success in Older Adults: A Retrospective Cohort Study in Taiwan.
Chang CP; Huang WH; You CH; Hwang LC; Lu IJ; Chan HL
Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31540355
[TBL] [Abstract][Full Text] [Related]
29. Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis.
Mills EJ; Wu P; Lockhart I; Thorlund K; Puhan M; Ebbert JO
Ann Med; 2012 Sep; 44(6):588-97. PubMed ID: 22860882
[TBL] [Abstract][Full Text] [Related]
30. Did the introduction of varenicline in England substitute for or add to the use of other smoking cessation medications?
Kotz D; Fidler JA; West R
Nicotine Tob Res; 2011 Sep; 13(9):793-9. PubMed ID: 21543548
[TBL] [Abstract][Full Text] [Related]
31. Does the nicotine metabolite ratio moderate smoking cessation treatment outcomes in real-world settings? A prospective study.
Shahab L; Bauld L; McNeill A; Tyndale RF
Addiction; 2019 Feb; 114(2):304-314. PubMed ID: 30276911
[TBL] [Abstract][Full Text] [Related]
32. Combined nicotine patch with gum versus nicotine patch alone in smoking cessation in Hong Kong primary care clinics: a randomised controlled trial.
Leung MKW; Bai D; Yip BHK; Fong MY; Lai PMH; Lai P; Lai ISY; Lam ZHW; Leung ATF; To DKY; Wong MT; Wong TK; Chao DVK
BMC Public Health; 2019 Oct; 19(1):1302. PubMed ID: 31619205
[TBL] [Abstract][Full Text] [Related]
33. Reach and effectiveness of mailed nicotine replacement therapy for smokers: 6-month outcomes in a naturalistic exploratory study.
Zawertailo L; Dragonetti R; Bondy SJ; Victor JC; Selby P
Tob Control; 2013 May; 22(3):e4. PubMed ID: 22496352
[TBL] [Abstract][Full Text] [Related]
34. Pharmacovigilance Assessment of Cardiac Implications of Nicotine Replacement Therapy Among Smokers.
Olawuyi O; Mathieson K
Curr Drug Saf; 2020; 15(3):173-180. PubMed ID: 32525783
[TBL] [Abstract][Full Text] [Related]
35. Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice.
Stapleton J; West R; Hajek P; Wheeler J; Vangeli E; Abdi Z; O'Gara C; McRobbie H; Humphrey K; Ali R; Strang J; Sutherland G
Addiction; 2013 Dec; 108(12):2193-201. PubMed ID: 23859696
[TBL] [Abstract][Full Text] [Related]
36. Treating heavy smokers in primary care with the nicotine nasal spray: randomized placebo-controlled trial.
Stapleton JA; Sutherland G
Addiction; 2011 Apr; 106(4):824-32. PubMed ID: 21205043
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Cardiovascular Safety for Smoking Cessation Pharmacotherapies in a Population-Based Cohort in Australia.
Havard A; Choi SKY; Pearson SA; Chow CK; Tran DT; Filion KB
JAMA Netw Open; 2021 Nov; 4(11):e2136372. PubMed ID: 34842922
[TBL] [Abstract][Full Text] [Related]
38. Varenicline and Nicotine Patch Therapies in Young Adults Motivated to Quit Smoking: A Randomized, Placebo-controlled, Prospective Study.
Tuisku A; Salmela M; Nieminen P; Toljamo T
Basic Clin Pharmacol Toxicol; 2016 Jul; 119(1):78-84. PubMed ID: 26709238
[TBL] [Abstract][Full Text] [Related]
39. French smoking cessation services provide effective support even to the more dependent.
Baha M; Boussadi A; Le Faou AL
Prev Med; 2016 Sep; 90():34-8. PubMed ID: 27346755
[TBL] [Abstract][Full Text] [Related]
40. Success of smoking cessation interventions during pregnancy.
Bérard A; Zhao JP; Sheehy O
Am J Obstet Gynecol; 2016 Nov; 215(5):611.e1-611.e8. PubMed ID: 27402053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
